首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1620218

全球注射包裝和組件市場規模（按包裝材料、注射、組件、劑量、地區、範圍和預測）

Global Injectable Packaging And Component Market Size By Packaging Material, By Parenteral, By Component, By Dosage, By Geographic Scope And Forecast

出版日期: 2024年11月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

注射包裝及組件市場規模及預測

近年來，注射劑包裝和組件的市場規模一直以適度的速度增長，增長率相當可觀，預計該市場在預測期內（即 2021-2028 年）將顯著增長。

注射藥物包裝可防止其成分進入外部環境參數。我們的產品線包括西林瓶、藥筒、預充式註射器和密封件，以及其他注射包裝和組件。藥物使用的增加、對個人化醫療的重視以及針對慢性疾病的新療法的出現推動了製藥業的成長。該研究報告對全球注射藥品包裝和組件市場進行了全面評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球注射包裝與組件市場定義

注射包裝透過填充藥物和成分並密封到一個緊湊的機器框架中，消除了與傳統加工相關的幾個步驟和額外成本。重量輕、無顆粒加工、耐破損、易於打開和回收能力是注射包裝與玻璃包裝的區別因素。注射藥物比口服藥物更複雜，並且更可能與環境暴露相互作用。結果表明，與活性物質接觸的容器對藥物沒有影響。注射藥物的包裝方式應使其成分不干擾外部環境參數。

西林瓶、藥筒、預充式註射器、密封件以及其他注射包裝和組件產品。注射包裝和組件分為小瓶、密封件、藥筒、注射器、安瓿等。小瓶是一種小容器，通常由塑膠或玻璃製成。與標準採血管不同，它們的形狀像管子或瓶子，底部平坦。根據您的特定存放和處理需求，小瓶可配備各種瓶蓋。藥筒是裝在註射器中用來給病人注射的物質的容器。

將藥筒插入註射器主體的開口中。藥物密封在金屬注射器內的藥筒中。安瓿是儲存不穩定元素的理想選擇，因為密封可以保護化學溶液免受污染。為了保持藥物穩定，藥廠在插入藥物之前先排除安瓿中的空氣。包裝能夠可靠地保護產品免受任何可能降低其性能或功效的外部因素的影響，例如光、濕度、氧氣、生物污染和偽造。

全球注射包裝和組件市場概覽

對生物製藥和藥品製造核心能力的關注、企業搬遷的需要、擁有成本以及作為組合產品一部分的組件的重要性日益增加，正在推動注射劑包裝和組件的發展，以下是四個主要因素。這些發展推動了對更高耐用性的需求。此外，藥物使用量的增加、對個人化醫療的日益關注以及慢性病創新療法的出現正在推動製藥業的成長。

由於製藥和生物技術行業的進步以及材料科學和製造方法的發展，注射包裝和組件市場正在發生重大變化。全球注射劑包裝和組件市場得到了成長的支撐，包括新興經濟體中產階級的不斷壯大、注射劑在藥品管道中所佔佔有率的增加以及癌症發病率的上升。

此外，患者自我管理需求的增加、包括細胞和基因療法在內的自然療法的多樣化，以及推動整體市場成長的 COVID-19 疫苗的前沿發展，都推動了藥品包裝的需求。口服固體製劑完全佔據市場主導地位，注射劑也正在快速成長。然而，有關藥品包裝的嚴格法律法規阻礙了市場的成長。

隨著監管要求的不斷提高以及對患者安全的關注，當前的注射劑包裝和組件市場面臨著如何盡快有效地將這種產品推向市場的課題，這阻礙了全球注射劑包裝和組件市場的發展。隨著新技術提高玻璃的穩定性、無菌性和保質期，製藥公司正在轉向採用柔性結構來包裝注射藥物，從而推動預測期內的市場成長。

Injectable drug packaging so that its constituents do not intrude with external environmental parameters. There are vials, cartridges, prefilled syringes, seals, as well as other injectable packaging and component product lines. The pharmaceutical industry's growth is fueled by increased medication use, a greater emphasis on personalized medicine, and the beginnings of new therapeutics for chronic health conditions. The Global Injectable Packaging And Component Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Injectable Packaging And Component Market Definition

Injectable packaging implicates filling and sealing drugs and components in a single compact machine frame, removing several of the steps and extra costs associated with conventional processing. Weight savings, particle-free processing, resistance to breakage, ease of opening, and recycling capacity differentiate injectable packaging from glass. Injectable drugs are more complicated than oral medications and can easily interact with environmental exposures. As an outcome, any container that makes contact with the active substance is demonstrated to not influence the drug. Injectable drug packaging is done in a way that its components do not interfere with outside environmental parameters.

Vials, cartridges and prefilled syringes, seals, as well as other injectable packaging and component products, are available. The Injectable Packaging and Components are classified as Vials, Seals, Cartridges, Syringes, Ampules, and Other. A vial is a small container that is generally made of plastic or glass. Unlike standard blood collection tubes, it is shaped like a tube or bottle and has a flat bottom. Vials are usable with a variety of caps to meet specific storage or handling necessities. A cartridge is a container of a substance used in a syringe to administer to a patient.

Insert the cartridge into the syringe body opening. The medicine is enclosed in a cartridge within the metal syringe. Ampoules are perfect for storing unstable elements because the seal protects the chemical from contamination. To ensure that the drug remains stable, drugs companies extract air from the ampoule before inserting the drug. The packaging ensures protection of the product from all external factors that degrade its performance or potency, including light, humidity, oxygen, biological contamination, as well as counterfeiting.

Global Injectable Packaging And Component Market Overview

The focus on biopharmaceutical and pharmaceutical manufacturing core competencies and the need for companies to move, the cost of ownership, and the growing significance of components as part of a combination product are the four major developments fueling the development of injectable packaging and components demand for higher durability. Moreover, Higher use of medicines, a growing focus on personalized medicine, and the rise of innovative therapies for chronic conditions are driving pharmaceutical industry growth.

The Injectable Packaging And Component Market is changing significantly as a result of the progression of the pharmaceutical and biotechnology industries, as well as developments in material science and manufacturing methods. The Global Injectable Packaging And Component Market is supported by growth such as the rising middle class in developing economies, the increasing share of injectables in the drug pipeline, a rise in cancer incidence, etc.

Furthermore, Pharmaceutical packaging essentials are influenced by using the increasing need for patient self-management and the increasing variety of natural therapies, including cell and gene therapies, as well as cutting-edge developments in COVID-19 vaccines leading to drive the overall growth of the market. Oral solid dosage forms completely dominate the market, and injectable medicines are increasing at a high rate. Nonetheless, the market's growth is hampered by strict laws and restrictions governing drug packaging.

With rising regulatory requirements and the prominence of patient safety, the current Injectable Packaging And Component Market is facing problems to bring this product to the market as quickly and effectively as possible leading to hindering the Global Injectable Packaging and Component Market. As new technology progresses stability, sterility, and shelf life over the glass, pharmaceutical companies are switching toward flexible structures for packaging injectable medicinal products leading to a rise in the growth of the market throughout the projected period.

Global Injectable Packaging And Component Market Segmentation Analysis

The Global Injectable Packaging And Component Market is Segmented on the basis of Packaging Material, Parenteral, Component, Dosage, And Geography.

Injectable Packaging And Component Market, By Packaging Material

Glass
Metal

Based on Packaging Material, The market is segmented into Glass and Metal. Glass has the highest growing segment of the Global Injectable Packaging and Components Market. Because of its high transparency, its contents are easily monitored. And it is highly resistive to air and moisture, it provides better protection as compared to metal over the projected period.

Injectable Packaging And Component Market, By Parenteral

Small Volume Parenteral
Large Volume Parenteral

Based on Parenteral, The market is segmented into Small Volume Parenteral and Large Volume Parenteral. The Small Volume Parenteral has the highest growing segment of the Global Injectable Packaging and Components Market. To establish specific parameters, establish drug quality, and maintain the drug's shelf life as compared to the large volume parenteral over the forecasted period.

Injectable Packaging And Component Market, By Component

Cartridges
Ampules
Vials
Syringes
Seals
Other

Based on Component, The market is segmented into Cartridges, Ampules, Vials, Syringes, Seals, Other. Vials have the largest growing segment of the Global Injectable Packaging and Components Market. The most common packaging material for liquid and freeze-dried injectables is glass vials. Plastic vials are less frequently used due to the ease with which glass is sterilized and transferred to aseptic environments over the projected period.

Injectable Packaging And Component Market, By Dosage

Single Dosage
Multi Dosage

Based on Dosage, The market is segmented into Single Dosage and Multi Dosage. A Single-Dose has the largest growing segment of the Global Injectable Packaging and Components Market A single dosage of a parenteral preparation that does not need to be tested for antimicrobial efficacy. A single dosage is designed to be used with a single patient for a single injection leading to an increase in the growth of the market globally.

Injectable Packaging And Component Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Injectable Packaging And Component Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the highest growing segment of the Global Injectable Packaging and Components Market. Factors include the rising incidence of chronic diseases, the growth of the Injectable Packaging And Component Market, and the increasing demands for self-injection devices over the forecasted period.

Key Players

The "Global Injectable Packaging And Component Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
West Pharmaceutical Services, Inc., Gerresheimer AG, Actiza Pharmaceutical Private Limited. Ypsomed Group, Injectapak, Pace Biotech, Aptar Pharma, and Datwyler Holding Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

1. INTRODUCTION OF GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
4.3. Porters Five Force Model
4.4. Value Chain Analysis

5. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PACKAGING MATERIAL

5.1. Overview
5.2. Glass
5.3. Metal

6. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PARENTERAL

6.1. Overview
6.2. Small Volume Parenteral
6.3. Large Volume Parenteral

7. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY COMPONENT

7.1. Overview
7.2. Cartridges
7.3. Syringes
7.4. Vials
7.5. Ampules
7.6. Seals
7.7. Other

8. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY DOSAGE

8.1. Overview
8.2. Single Dosage
8.3. Multi Dosage

9. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.3 Canada
- 9.2.4 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East and Africa

10. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET COMPETITIVE LANDSCAPE

10.1. Overview
10.2. Company Market Ranking
10.3. Key Development Strategies

11. COMPANY PROFILES

11.1 West Pharmaceutical Services
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Gerresheimer AG
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Actiza Pharmaceutical Private Limited
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Ypsomed Group
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Datwyler Holding Inc.
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Injectapak
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Pace Biotech
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Aptar Pharma
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments